■由于血泡状动脉瘤(BBA)引起的蛛网膜下腔出血(SAH)很少见,但在治疗期间非常危险。此外,没有确定的治疗方法。在这项研究中,我们对亚急性期SAH患者进行了血管内治疗(EVT)作为一线治疗,并对这一系列病例进行了分析。
■在2021年4月至2023年3月期间访问我们医院的SAH患者被纳入本研究。我们在急性期尽可能长时间地等待,并在亚急性期进行EVT。我们进行了支架辅助卷绕(SAC)作为一线治疗,并在治疗后约6个月进行了DSA。
■96例SAH患者在研究期间到我院就诊,6例因BBA而出现SAH。男性2例,女性4例,年龄56.2±14.6岁。我们对五名患者进行了SAC,1人因治疗前再出血死亡.两名患者因再出血接受治疗。一名患者在再次出血后的第二天死亡,而另一个经历了两次再出血和治疗,并取得了良好的结果。4例患者预后良好(改良Rankin量表[mRS]:0)。存活的患者在DSA随访时达到完全闭塞。然而,2例患者预后较差(mRS:6).
■在亚急性期接受BBA治疗的SAH患者可能会取得良好的预后;然而,在等待期间有再出血的风险,这往往会导致糟糕的结果。
UNASSIGNED: Subarachnoid hemorrhage (SAH) due to blood blister-like aneurysm (BBA) is rare but very risky during treatment. Moreover, there is no established treatment method. In this study, we performed endovascular treatment (EVT) as the first-line treatment on patients with SAH during the subacute phase, and cases were analyzed in this series.
UNASSIGNED: Patients with SAH due to BBA who visited our hospital between April 2021 and March 2023 were enrolled in this study. We waited as long as possible during the acute phase and performed EVT during the subacute phase. We performed stent-assisted coiling (SAC) as the first-line treatment and performed DSA approximately 6 months after treatment.
UNASSIGNED: Ninety-six patients with SAH visited our hospital during the study period and six had SAH due to BBAs. There were two males and four females aged 56.2 ± 14.6 years. We performed SAC in five patients, and one died owing to rebleeding before treatment. Two patients received treatments because of rebleeding. One patient died on the day after rebleeding, whereas the other experienced rebleeding and treatments twice and achieved a good outcome. Four patients had good outcomes (modified Rankin scale [mRS]: 0). The surviving patients achieved complete occlusion at follow-up DSA. However, two patients had poor outcomes (mRS: 6).
UNASSIGNED: Patients with SAH due to BBA treated in the subacute phase may achieve good outcomes; however, there is a risk of rebleeding during the waiting period, which often causes poor outcomes.